Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein.
about
Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein.Tolerance and autoimmunity in TCR transgenic mice specific for myelin basic protein.Association of HLA and T-cell receptor gene polymorphisms with Semple rabies vaccine-induced autoimmune encephalomyelitis.Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes.Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen.Experimental autoimmune encephalomyelitis in the mouse.'Multi-epitope-targeted' immune-specific therapy for a multiple sclerosis-like disease via engineered multi-epitope protein is superior to peptidesPeptide-based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities.Antigen-specific tolerance as a therapy for experimental autoimmune encephalomyelitis.EAE: a model for immune intervention with synthetic peptides.Experimental Autoimmune Encephalomyelitis in MiceA study of experimental autoimmune encephalomyelitis in dogs as a disease model for canine necrotizing encephalitis.An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis.T cell determinants of myelin basic protein include a unique encephalitogenic I-E-restricted epitope for Lewis rats.T cell targeted immunotherapy for autoimmune disease.Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitisA predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical diseaseIL-12 unmasks latent autoimmune disease in resistant mice.Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis.Microbial epitopes act as altered peptide ligands to prevent experimental autoimmune encephalomyelitisHigh frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoire.In vivo survival of viral antigen-specific T cells that induce experimental autoimmune encephalomyelitis.High cell surface expression of CD4 allows distinction of CD4(+)CD25(+) antigen-specific effector T cells from CD4(+)CD25(+) regulatory T cells in murine experimental autoimmune encephalomyelitis.Autoimmunity to collagen II and myelin basic protein: comparative studies in humans and rodents.Antigen recognition and peptide-mediated immunotherapy in autoimmune disease.Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.Prospects for immunotherapy directed to the T cell receptor in human autoimmune disease.Interaction of T lymphocytes with cerebral endothelial cells in vitro.Antigen-specific therapy of multiple sclerosis: the long-sought magic bullet.A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis.New findings and old controversies in the research of multiple sclerosis and its model experimental autoimmune encephalomyelitis.Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma.The relationship between human multiple sclerosis and rodent experimental allergic encephalomyelitis.Chronicity of tissue-specific experimental autoimmune disease: a role for B cells?Cell-based gene therapy experiments in murine experimental autoimmune encephalomyelitis.Specific immunoregulation of the induction and effector stages of relapsing EAE via neuroantigen-specific tolerance induction.Influence of a dominant cryptic epitope on autoimmune T cell tolerance.Modulation of experimental autoimmune encephalomyelitis by VLA-2 blockade.Altered peptide ligands of myelin basic protein ( MBP87-99 ) conjugated to reduced mannan modulate immune responses in miceThe case against epitope spread in experimental allergic encephalomyelitis
P2860
Q33671509-336C2EAC-3F20-4DDD-ACCD-B7B321539FDBQ33713319-CDA5A4F8-3843-4B93-978E-9722CA9D1BEEQ33861609-68B7BF50-C1F7-4EC5-81F4-5CAB6637122CQ33947082-DB99AFA9-D948-4EAF-BCD2-6075DBBD9886Q33992633-6A8F5785-BC38-4FE6-AC8A-874CF9724EA0Q34041971-254653A6-D2C3-4BD3-A909-55902F6E6219Q34091080-99F6EDBF-AC99-4825-90BE-C8FC10E48BE1Q34567730-F1E183C9-A601-465D-BD15-4B0F5622D17FQ35173096-424AC4B1-2772-46C0-A3D4-0F61FFC20354Q35173105-FF7CF273-EA70-461E-8E2B-8F441CD1A0B0Q35472583-A4AFC02D-8CF7-4439-9F8E-99DCD4E88BFBQ35790269-B6D93D3D-83AC-461E-A6AA-E1E1E687917EQ36353675-96B7074D-A6A0-4BD2-8EDA-F9FE90E53063Q36356697-16553B60-EF16-4F7B-95A5-BB08FCD61258Q36359571-4575425E-1A79-4C7F-8FF4-75458854D512Q36365105-7C7DD0F2-4A4E-4ED1-9F01-FC2058AA4F0BQ36366545-D9C8440E-006E-4079-8455-D67D84D01E7CQ36367147-D753B266-985A-480B-84DC-839AF99F6502Q36368003-4BE007E7-3CBB-47FB-B3A6-196E2BEEDA4AQ36368042-91EFA680-763A-40DC-961B-30DE1E625970Q36376026-D7599DFC-2FE1-4EDF-9B9D-8357DBB832D9Q36401750-73EAAB15-FB0D-43EC-AE75-357D04E12937Q36401977-F1A756DA-E24E-4961-B2C2-36F13855A8C6Q36635302-B85B70F5-B47D-40AB-904A-0849076E2BECQ36635307-1A42FDEC-7EEE-4989-B047-72B5D7CB0936Q36642040-3899F79A-01F3-45AD-BFF7-51A7FA9F71C1Q36715655-F0A6636A-46F4-4A6A-BB0B-44AF96A4E85DQ36725418-3C505E8A-9901-404B-92DB-163A9A46813CQ36963194-3F40869D-3AA4-4757-88C4-3AFC59C03AB5Q37611832-074EEA0F-2C62-4E77-B50C-1E070C6EE1FFQ38103283-F61F4937-9151-422C-A494-B90BF6AE8F5FQ40348077-ECE11AF3-80A1-4FF5-8AE2-E08AF85E5843Q40403377-8544F82E-4BD3-4593-B22F-B1E9B0BDBD59Q40433189-9293A738-6864-47C8-A105-E1D12AEA93CEQ40445781-CB793268-6160-4619-AF30-319D5D218F8FQ41902251-A4377001-E2CC-4B35-ACB1-EDCF9993D02CQ43867718-B45D0028-FDCD-40FD-8F07-27126482210AQ48173043-7C6F83A8-0781-45E0-8D82-9D0759CB2B2AQ57594229-07A94181-6A3F-49E5-B398-D57F6295A8EAQ57704239-C5474E4D-CEF7-4CAF-9123-E8CD738CEAEE
P2860
Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Characterization of a major en ...... tides of myelin basic protein.
@en
Characterization of a major en ...... tides of myelin basic protein.
@nl
type
label
Characterization of a major en ...... tides of myelin basic protein.
@en
Characterization of a major en ...... tides of myelin basic protein.
@nl
prefLabel
Characterization of a major en ...... tides of myelin basic protein.
@en
Characterization of a major en ...... tides of myelin basic protein.
@nl
P2093
P1476
Characterization of a major en ...... tides of myelin basic protein.
@en
P2093
P356
10.1016/0165-5728(88)90032-X
P577
1988-08-01T00:00:00Z